CCNO and B-cell chronic lymphocytic leukemia: The AF/CCNU combinations were synergistic at all dose levels in the 1771 and CLL-1390 cell lines (CI < 1), and synergistic effects were also exhibited in OSW and CLBL-1 cells, except at high dose levels, i.e. ED95.